Tech/Science

  • Opening the Door to Regenerative Medicine: iPS Cardiac Muscle Sheets

    On April 8, 2025, Japan’s regenerative medicine reached a historic turning point. Cuorips Inc., a biotech venture spun out of Osaka University, announced it had submitted a marketing authorization application to Japan’s Ministry of Health, Labour and Welfare (MHLW) for a “cardiomyocyte sheet” created from human induced pluripotent stem (iPS) cells. This is believed to be the world’s first marketing application aiming to commercialize a regenerative medicine product using iPS cells, and it has generated great anticipation across the scientific and medical communities.

    By Honourway Asia Pacific Limited

  • H3 Rocket’s Redemptive Flight, “Michibiki” Lighting the Future

    At 5:30 p.m. JST on February 2, 2025, a streak of light shot into the sky from the Tanegashima Space Center in Kagoshima Prefecture. Japan’s new flagship launch vehicle, the H3 (Flight 5), roared off the pad and left the earth behind. This launch was more than just another mission; it was the climactic chapter in a story of redemption and renewal for Japan’s space program. The cheers and applause that reverberated through the control room spoke more eloquently than anything else to the weight of this success.

    By Honourway Asia Pacific Limited

  • Japan’s Tech Revival: New Stars Shine at CES

    January 2025, Las Vegas. More than 140,000 people flocked to CES, one of the world’s largest technology trade shows, in search of the future. In a corner of Eureka Park, the startup-only area, Japan’s technological innovation was breathing anew.

    By Honourway Asia Pacific Limited

POPULAR ARTICLES